Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mistletoe in early breast cancer pilot trial
2011-001224-37Phase 3Terminated
- Sponsor
- Research, Enterprise and Development
- Start
- Oct 2011
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in breast cancer comparing Helixor M plus standard cancer treatment with Placebo plus standard cancer treatment (2 arms). Primary endpoint: Primary feasibility endpoint. Started Oct 2011; status: terminated.
02
Drugs
viscum album extract
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2011-001224-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001224-37.